XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 30, 2024
Jan. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,885,603 $ 1,558,252
Marketable securities 5,488,737 5,404,233
Accounts receivable, net of allowances of $22,009 and $32,371 as of April 30, 2024 and January 31, 2024, respectively 527,515 536,078
Deferred contract acquisition costs, current 198,113 208,474
Prepaid expenses and other current assets 182,077 219,182
Total current assets 8,282,045 7,926,219
Deferred contract acquisition costs, noncurrent 121,087 138,724
Property and equipment, net 304,712 293,704
Operating lease right-of-use assets 55,750 58,975
Strategic investments 424,923 409,222
Goodwill 307,295 307,295
Deferred tax assets 673,808 662,177
Other assets, noncurrent 127,010 133,477
Total assets 10,296,630 9,929,793
Current liabilities:    
Accounts payable 18,315 10,175
Accrued expenses and other current liabilities 501,799 500,164
Deferred revenue, current 1,335,787 1,251,848
Total current liabilities 1,855,901 1,762,187
Deferred revenue, noncurrent 16,405 18,514
Operating lease liabilities, noncurrent 40,284 48,308
Other liabilities, noncurrent 85,216 81,378
Total liabilities 1,997,806 1,910,387
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of April 30, 2024 and January 31, 2024; 263,636,337 and 260,896,822 shares issued and outstanding as of April 30, 2024 and January 31, 2024, respectively; 300,000,000 Class B shares authorized as of April 30, 2024 and January 31, 2024; 45,632,347 and 46,661,531 shares issued and outstanding as of April 30, 2024 and January 31, 2024, respectively 309 307
Additional paid-in capital 5,310,417 5,228,756
Accumulated other comprehensive (loss) income (17,490) 1,063
Retained earnings 3,005,588 2,789,280
Total stockholders’ equity 8,298,824 8,019,406
Total liabilities and stockholders’ equity $ 10,296,630 $ 9,929,793